Experimental stem cell treatment offers hope for deadly transplant complication
NCT ID NCT00284986
Summary
This study tested whether Prochymal, a stem cell therapy, could help patients with severe graft-versus-host disease (GVHD) that hadn't responded to standard treatments. GVHD is a dangerous complication that can occur after a bone marrow transplant, where the donor cells attack the patient's body. The trial enrolled 11 patients with life-threatening GVHD to see if the stem cell infusions could reduce symptoms and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT -VERSUS-HOST-DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27708, United States
Conditions
Explore the condition pages connected to this study.